GGrantIndex
← Leaderboards

Zhaoping Li

University Of California At Davis

$3,040,681
Attributed
$12,394,088
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,394,088 · 2
VA$0 · 3

By mechanism

UG1$11,224,088 · 1
R01$1,170,000 · 1
I01$0 · 3

Most similar at University Of California At Davis

Same institution · by research overlap

Others in their field

Top investigators on “Complex

Research focus

ComplexResponseEnvironmental Risk FactorCellsPhenotypeMetabolicBloodGeneticMediatingMolecularMicrobiomeFoodFatty Acid Glycerol EstersMetabolomicsIndividual ResponseDietary InterventionDietClinical TrialsInter-Individual VariationIn VitroGut MicrobiotaDietaryMicrobiotaPharmaceutical Preparations

Grant awards (18)

California Partnership for Personalized Nutrition$3,111,874
UG1 · FY2025 · HD
Pomegranate Extract and Its Microbial Metabolite Urolithin A Suppress IBD through Modulation of the Gut Microbiome and T Cell Inflammatory Immune Responses$0
I01 · FY2025 · VA · contact PI
California Partnership for Personalized Nutrition$3,111,874
UG1 · FY2024 · HD
Pomegranate Extract and Its Microbial Metabolite Urolithin A Suppress IBD through Modulation of the Gut Microbiome and T Cell Inflammatory Immune Responses$0
I01 · FY2024 · VA · contact PI
California Partnership for Personalized Nutrition$2,911,874
UG1 · FY2023 · HD
Pomegranate Extract and Its Microbial Metabolite Urolithin A Suppress IBD through Modulation of the Gut Microbiome and T Cell Inflammatory Immune Responses$0
I01 · FY2023 · VA · contact PI
California Partnership for Personalized Nutrition$1,088,463
UG1 · FY2022 · HD
California Partnership for Personalized Nutrition$1,000,003
UG1 · FY2022 · HD
Pomegranate Extract and Its Microbial Metabolite Urolithin A Suppress IBD through Modulation of the Gut Microbiome and T Cell Inflammatory Immune Responses$0
I01 · FY2022 · VA · contact PI
BCAA Catabolic Defect in HF: Novel Mechanism and Therapeutic Target$390,000
R01 · FY2021 · HL · contact PI
BCAA Catabolic Defect in HF: Novel Mechanism and Therapeutic Target$390,000
R01 · FY2020 · HL · contact PI
BCAA Catabolic Defect in HF: Novel Mechanism and Therapeutic Target$390,000
R01 · FY2019 · HL · contact PI
Effects of Broccoli Sprout Extract on Allergic Rhinitis$0
I01 · FY2019 · VA · contact PI
Effects of Broccoli Sprout Extract on Allergic Rhinitis$0
I01 · FY2018 · VA · contact PI
Effects of Broccoli Sprout Extract on Allergic Rhinitis$0
I01 · FY2017 · VA · contact PI
Development of A Novel Anti-Hyperglycemic Agent$0
I01 · FY2012 · VA · contact PI
Development of A Novel Anti-Hyperglycemic Agent$0
I01 · FY2011 · VA · contact PI
Development of A Novel Anti-Hyperglycemic Agent$0
I01 · FY2009 · VA · contact PI